These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19427181)

  • 1. Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland.
    Thorleifsson SJ; Margretardottir OB; Gudmundsson G; Olafsson I; Benediktsdottir B; Janson C; Buist AS; Gislason T
    Respir Med; 2009 Oct; 103(10):1548-53. PubMed ID: 19427181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension, systemic inflammation and body weight in relation to lung function impairment-an epidemiological study.
    Margretardottir OB; Thorleifsson SJ; Gudmundsson G; Olafsson I; Benediktsdottir B; Janson C; Buist AS; Gislason T
    COPD; 2009 Aug; 6(4):250-5. PubMed ID: 19811383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in the association between C-reactive protein, lung function impairment, and COPD.
    Olafsdóttir IS; Gíslason T; Thjódleifsson B; Olafsson I; Gíslason D; Jõgi R; Janson C
    Int J Chron Obstruct Pulmon Dis; 2007; 2(4):635-42. PubMed ID: 18268938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airflow obstruction, atherosclerosis and cardiovascular risk factors in the AGES Reykjavik study.
    Gudmundsson G; Margretardottir OB; Sigurdsson MI; Harris TB; Launer LJ; Sigurdsson S; Olafsson O; Aspelund T; Gudnason V
    Atherosclerosis; 2016 Sep; 252():122-127. PubMed ID: 27522264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchial airflow limitation, smoking, body mass index, and statin use are strongly associated with the C-reactive protein level in the elderly. The Tromsø Study 2001.
    Melbye H; Halvorsen DS; Hartz I; Medbø A; Brox J; Eggen AE; Njølstad I
    Respir Med; 2007 Dec; 101(12):2541-9. PubMed ID: 17825547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
    Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE
    Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
    Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiography, spirometry, and systemic acute-phase inflammatory proteins in smokers with COPD or CHF: an observational study.
    Beghé B; Verduri A; Bottazzi B; Stendardo M; Fucili A; Balduzzi S; Leuzzi C; Papi A; Mantovani A; Fabbri LM; Ceconi C; Boschetto P
    PLoS One; 2013; 8(11):e80166. PubMed ID: 24244639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.
    Karrasch S; Brüske I; Smith MP; Thorand B; Huth C; Ladwig KH; Kronenberg F; Heinrich J; Holle R; Peters A; Schulz H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1881-94. PubMed ID: 27574413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily step count is associated with plasma C-reactive protein and IL-6 in a US cohort with COPD.
    Moy ML; Teylan M; Weston NA; Gagnon DR; Danilack VA; Garshick E
    Chest; 2014 Mar; 145(3):542-550. PubMed ID: 24091482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic inflammation, depression and obstructive pulmonary function: a population-based study.
    Lu Y; Feng L; Feng L; Nyunt MS; Yap KB; Ng TP
    Respir Res; 2013 May; 14(1):53. PubMed ID: 23676005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
    Long H; Luo H; Chen P; Li Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of inflammation biomarkers among chronic obstructive pulmonary disease groups: A cross sectional study.
    Yazici O; Gulen ST; Yenisey C; Eryilmaz U; Abas BI; Polatli M
    Niger J Clin Pract; 2020 Jun; 23(6):817-824. PubMed ID: 32525117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS.
    Garudadri S; Woodruff PG; Han MK; Curtis JL; Barr RG; Bleecker ER; Bowler RP; Comellas A; Cooper CB; Criner G; Dransfield MT; Hansel NN; Paine R; Krishnan JA; Peters SP; Hastie AT; Martinez FJ; O'Neal WK; Couper DJ; Alexis NE; Christenson SA
    Chest; 2019 May; 155(5):908-917. PubMed ID: 30684474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of stable chronic obstructive pulmonary disease related to systemic inflammation].
    Solanes I; Bolíbar I; Llauger MA; Medrano C; Peiró M; Fraga M; Pou MA; Giner J; Freixas M; Plaza V;
    Med Clin (Barc); 2012 Oct; 139(10):430-6. PubMed ID: 22766062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical Activity in Overlap Syndrome of COPD and Obstructive Sleep Apnea: Relationship With Markers of Systemic Inflammation.
    Fitzgibbons CM; Goldstein RL; Gottlieb DJ; Moy ML
    J Clin Sleep Med; 2019 Jul; 15(7):973-978. PubMed ID: 31383234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of airflow obstruction in nonsmoking older individuals using different spirometric criteria: the AGES Reykjavik Study.
    Runarsdottir SB; Gudmundsson G; Aspelund T; Harris TB; Launer LJ; Gudnason V; Gislason T
    COPD; 2013 Aug; 10(4):493-9. PubMed ID: 23875743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mediating role of cytokine IL-6 on the relationship of FEV₁ upon 6-minute walk distance in chronic obstructive pulmonary disease.
    Baldi S; Jose PE; Bruschi C; Pinna GD; Maestri R; Rezzani A; Bellinzona E; Fracchia C; Dacosto E; Crotti P; Montemartini S
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1091-9. PubMed ID: 25336940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small airways obstruction and its risk factors in the Burden of Obstructive Lung Disease (BOLD) study: a multinational cross-sectional study.
    Knox-Brown B; Patel J; Potts J; Ahmed R; Aquart-Stewart A; Cherkaski HH; Denguezli M; Elbiaze M; Elsony A; Franssen FME; Ghobain MA; Harrabi I; Janson C; Jõgi R; Juvekar S; Lawin H; Mannino D; Mortimer K; Nafees AA; Nielsen R; Obaseki D; Paraguas SNM; Rashid A; Loh LC; Salvi S; Seemungal T; Studnicka M; Tan WC; Wouters EEFM; Barbara C; Gislason T; Gunasekera K; Burney P; Amaral AFS;
    Lancet Glob Health; 2023 Jan; 11(1):e69-e82. PubMed ID: 36521955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.